Medication info

B Braun Hartmann Solution

Prescription medicationInjectionsIntravenous injectionApproval withdrawn
Ingredient · strength
Sodium Chloride›0.6g / 100mLPotassium Chloride›0.04g / 100mLCalcium Chloride Hydrate›0.027g / 100mLSodium Lactate›0.312g / 100mL
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
A colorless injectable solution filled in a polyethylene container
Packaging
Bottle - 500 milliliters/bottle, Bottle - 1000 milliliters/bottle
Approval status
Approval withdrawn

MFDS item code 200210370 · Notified 2002.05.06

This product's status changed to Approval withdrawn on 2024.12.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Replacement and correction of extracellular fluid deficits; correction of metabolic acidosis
Who receives it
Adults
Adult administration
Usually, adults receive 500~1,000mL per dose by intravenous infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Replacement and correction of extracellular fluid deficits; correction of metabolic acidosis

View approved original text

This medication helps balance extracellular fluid when circulating blood volume and interstitial fluid are decreased. It is also used to improve metabolic acidosis conditions and regulate the body's acid-base balance. Therefore, it is effective in maintaining healthy bodily fluids and acid-base balance.

How it is given

Adult administration

Usually, adults receive 500~1,000mL per dose by intravenous infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Precautions

This medication is a calcium-containing solution administered intravenously. When using this medication, it is essential to administer it separately from the antibiotic Ceftriaxone when using the same infusion apparatus, as Ceftriaxone and calcium can precipitate and be dangerous. Allergic reactions may occur during administration, so if symptoms such as hives, rash, or difficulty breathing appear, immediately stop the administration and seek appropriate treatment. Due to the high potassium content, there is a risk of elevated potassium levels in the blood; therefore, patients with poor kidney function, dehydration, or cardiac conditions should be particularly cautious and may need to check serum potassium levels frequently. It may also increase sodium and chloride levels, so patients with hypertension, congestive heart failure, or liver disease should use this medication cautiously to avoid fluid overload or electrolyte imbalance, with regular blood tests and kidney function evaluations. Additionally, this medication can cause hyponatremia, so at-risk groups such as children, the elderly, postoperative patients, and patients with mental disorders should be closely monitored for symptoms and have serum sodium levels monitored. Patients with high calcium levels or a history of calcium kidney stones should avoid administration of this medication. Rapid or excessive administration of this medication can lead to side effects such as cerebral edema, pulmonary edema, and peripheral edema, so the administration rate and dosage must be adjusted. This medication should be used with caution in patients with diminished kidney function, heart failure, dehydration, severely impaired liver function, and urinary obstruction. During pregnancy, it should only be used when necessary after considering the risks to the fetus, and care should be taken when administering to children or newborns due to the higher risk of hyponatremia and brain damage. This medication may interact with various other drugs, so particularly when used with drugs that cause hyperkalemia, lithium, digoxin, diuretics, anticonvulsants, corticosteroids, etc., consultation with a healthcare professional is recommended, and blood tests should be performed to monitor the condition. Before administration, disinfect the skin and equipment to prevent infection, and warm the solution to body temperature before use; any remaining solution should be disposed of immediately after opening. Administer the solution slowly intravenously to reduce the risk of adverse effects. Finally, this medication should be stored at room temperature and must be administered strictly according to healthcare provider instructions.

Side effects

  • Anaphylaxis
  • hypersensitivity
  • hyperkalemia
  • hypernatremia
  • hyperchloremia
  • metabolic acidosis
  • electrolyte imbalance
  • fluid overload
  • hyponatremia
  • cerebral edema
Show 13 more
  • pulmonary edema
  • peripheral edema
  • systemic papules and erythema
  • rash
  • urticaria
  • vomiting
  • hypertension
  • tachycardia
  • chills
  • fever
  • hyponatremic encephalopathy
  • cardiac arrest
  • infusion site pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress. It is also advisable to keep it away from direct sunlight and store it at room temperature.

Appearance and packaging

Appearance

A colorless injectable solution filled in a polyethylene container

Package unit

Bottle - 500 milliliters/bottle, Bottle - 1000 milliliters/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.